Priority Review Voucher Fee Decreases For FY 2021 May Reflect US FDA Personnel Changes

fee decrease
The FY 2021 priority review voucher user fee decreased more than 37% from the previous year. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from User Fees

More from Pathways & Standards